title: Editorial: ONO-2952 in irritable bowel syndrome with diarrhoea - authors' reply.
authors.affiliation: Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
authors.forename: W E
authors.identifier: 0000-0001-6587-7602
authors.initials: WE
authors.lastname: Whitehead
authors.affiliation: Ono Pharma UK Ltd, London, UK.
authors.forename: K
authors.initials: K
authors.lastname: Duffy
authors.affiliation: Ono Pharma UK Ltd, London, UK.
authors.forename: J
authors.initials: J
authors.lastname: Sharpe
authors.affiliation: Ono Pharma UK Ltd, London, UK.
authors.forename: T
authors.initials: T
authors.lastname: Nabata
authors.affiliation: Ono Pharma UK Ltd, London, UK.
authors.forename: M
authors.initials: M
authors.lastname: Bruce
mesh_terms: D003521:Cyclopropanes; D003967:Diarrhea; D006576:Heterocyclic Compounds, 4 or More Rings; D006801:Humans; D043183:Irritable Bowel Syndrome
chemical_list: D003521:Cyclopropanes; D006576:Heterocyclic Compounds, 4 or More Rings; C000607300:ONO-2952